State Ledger
Company profile

BioAtla, Inc. CIK 1826892

Ticker
BCAB (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
San Diego, CA 92121
Fiscal year end
2025 (FY)
Market Data
Close
$1.79
Change
+$0.00
Change %
0.00%
Volume
0

BCAB · trading date Oct 9, 2026 · previous close $1.79 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$59.61M
Total assets
$13.83M
Total liabilities
$50.02M
Stockholders' equity
-$36.19M
Cash & equivalents
$7.12M
Operating income
-$59.31M
Operating cash flow
-$48.20M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
361.7%
Equity / assets
-261.7%
CapEx / revenue
—
Operating cash flow / net income
0.81×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$59.61M $13.83M $50.02M -$36.19M
2024 — -$69.78M $52.42M $38.16M $14.27M
2023 — -$123.46M $119.66M $48.99M $70.67M
2022 — -$106.48M $225.74M $45.40M $180.34M
2021 $300.0K -$95.40M $254.42M $43.60M $210.82M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-02
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92121
11085 TORREYANA ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies